MacLeods Pharma recalls
4 federal recalls on file, showing the 3 from the last 12 months. We read every CPSC, FDA, USDA and NHTSA notice for MacLeods Pharma and put it in plain English.
Recent recalls
Macleods Pharma blood pressure tablets recalled for failed dissolutionMacleods Pharma USA is recalling specific lots of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide combination tablets (40 mg/10 mg/12.5 mg) because they failed to meet dissolution specifications. This means the tablets may not break down properly in the body, potentially reducing how well the medication works.
ModerateFDAOct 26, 2026
- Macleods Olanzapine tablets recalled for impurity contamination
Macleods Pharmaceuticals has recalled Olanzapine Tablets USP 5 mg (lot BOB22321A, expiring 07-31-2027) because testing found organic impurities above acceptable limits. The affected bottles were distributed nationwide. No injuries have been reported.
ModerateFDASep 30, 2026
- Macleods levothyroxine tablets recalled for subpotency
Macleods Pharma USA is recalling Levothyroxine Sodium Tablets USP 150 mcg because they may contain less active ingredient than labeled. This means the medication may not work as intended to treat thyroid conditions. The affected lot is 16240062A with an expiration date of March 2026.
ModerateFDAApr 1, 2026